Aardvark Therapeutics, Inc. AARD
Set alert
1.20 USD -0.16 -11.76%
At close
1.29 +0.09 +7.47%
Pre-market · Nov 3, 4:23 AM ET
1.20 Day range 1.40
0.93 52-week range 16.60
- YTD
- -90.86%
- 1 year
- -88.45%
- Open
- 1.37
- Prev close
- 1.36
- Mkt cap
- 26.26M
- Vol
- 343.52K
- Avg vol
- 592.00K
- EPS
- -3.21
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.20
- High
- 1.40
1Y chart
Signals (44)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 7, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 28, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 24, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 22, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| RSI: Overbought | Jul 10, 2026 | 3 months ago |
| RSI: Overbought | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 15, 2026 | 4 months ago |
| MACD: Sell Signal | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
| SMA: Bullish | May 5, 2026 | 6 months ago |
| RSI: Oversold | Apr 8, 2026 | 6 months ago |
Newest 20 of 44.
Financials — quick view
AARD Revenue — quarterly 0
AARD Net income — quarterly -14.39M
AARD EPS — quarterly -0.66
News
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- HC Wainwright & Co. Maintains Neutral on Aardvark Therapeutics, Lowers Price Target to $2
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Aardvark Therapeutics Says Current Prader-Willi Syndrome Drug Data Insufficient
- Dow Tumbles Over 500 Points; American Express Shares Fall After Q3 Results
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Aardvark Therapeutics Reports Exploratory Phase 3 HERO And OLE Data Showing Rapid Hunger Score Reductions With ARD-101 In PWS, FDA Lifts Clinical Hold And Company Targets New Phase 3 Trial
- Why RingCentral Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Your note
Sign in to keep a note on AARD — it syncs with the Stock Master app.